Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.55 |
| ▸ | KDM1A | O60341 | 12/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.49 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.49 |
| ▸ | PRNP | P04156 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.49 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5112085 | 1.00 | PIM1 (0.55) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL16616420 | 0.94 | PIM1 (0.49) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL31174404 | 0.94 | PDF (0.53) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL19746326 | 0.91 | PIM1 (0.48) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL8715162 | 0.91 | KDM1A (0.54) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL25842328 | 0.87 | PDF (0.48) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL29376040 | 0.87 | PDF (0.48) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL19745946 | 0.87 | CYP2D6 (0.71) | KDM1ASIGMAR1SLC22A1PRNPTP53 | |
| SCHEMBL31174406 | 0.86 | PDF (0.43) | PIM1KDM1ASIGMAR1SLC22A1PRNP | |
| SCHEMBL27766622 | 0.86 | PDF (0.43) | PIM1KDM1ASIGMAR1SLC22A1PRNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7351508-B2 | Organophotoreceptors with a charge transport material having multiple vinyl-containing hydrazone groups | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-04-01 | — | — | US | disclosed |
| US-7189483-B2 | Charge transport materials having heteroaromatic hydrazone groups | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-03-13 | — | — | US | disclosed |
| US-20060078351-A1 | Organophotoreceptors with a charge transport material having multiple vinyl-containing hydrazone groups | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-04-13 | — | — | US | disclosed |
| US-20040241563-A1 | Novel charge transport materials having heteroaromatic hydrazone groups | S-PRINTING SOLUTION CO., LTD. (KR) | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040241563-A1 | Novel charge transport materials having heteroaromatic hydrazone groups | SLC43A1, SLC7A5, SLC35E1 | PIM1 4123/4885KDM1A 2383/4885SIGMAR1 502/4885 |
| US-20060078351-A1 | Organophotoreceptors with a charge transport material having multiple vinyl-containing hydrazone groups | SLC16A7, SLC16A1, SLC16A3 | PIM1 3923/4885KDM1A 2281/4885SIGMAR1 2061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.